LCM
CLPT icon

Legato Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Legato Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-67,119
Closed -$1.46M – 764
2025
Q3 		$1.46M Sell
67,119
-29,839
-31% -$351K 0.16% 192
2025
Q2 		$1.16M Sell
96,958
-231
-0.2% -$2.91K 0.14% 239
2025
Q1 		$1.16M Sell
97,189
-24,868
-20% -$387K 0.16% 215
2024
Q4 		$1.88M Sell
122,057
-36,911
-23% -$478K 0.25% 119
2024
Q3 		$1.78M Hold
158,968
– – 0.22% 145
2024
Q2 		$857K Buy
158,968
+28,227
+22% +$163K 0.12% 295
2024
Q1 		$889K Buy
+130,741
New +$914K 0.11% 301
2023
Q2 		– Sell
-62,562
Closed -$528K – 583
2023
Q1 		$528K Hold
62,562
– – 0.1% 344
2022
Q4 		$530K Buy
+62,562
New +$593K 0.1% 336

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
FCM
FirstWave Capital Management Miami, Florida $94.1M AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Legato Capital Management's CLPT Position: Q4 2025 in Review

Legato Capital Management sold out of ClearPoint Neuro (CLPT) in Q4 2025, closing a stake of 67,119 shares — an estimated $1.46M sold.

Legato Capital Management first reported a position in CLPT in Q4 2022 and held it in 9 quarters. The position peaked at $1.88M in Q4 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q4 2025.

  • Legato Capital Management reported no remaining ClearPoint Neuro position as of Q4 2025 after selling out during the quarter.
  • Legato Capital Management sold 67,119 ClearPoint Neuro shares in Q4 2025, an estimated $1.46M.
  • Legato Capital Management first reported a position in ClearPoint Neuro in Q4 2022 and held it in 9 quarters.
  • Legato Capital Management's ClearPoint Neuro position peaked at $1.88M in Q4 2024.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2025.

Based on Legato Capital Management's 13F filing for Q4 2025, filed 6 Feb 2026.